• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Jacob M. Hooker, PhD


  • Wang C, Eessalu TE, Barth VN, Mitch CH, Wagner FF, Hong Y, Neelamegam R, Schroeder FA, Holson EB, Haggarty SJ, Hooker JM.Design, synthesis, and evaluation of hydroxamic acid-based molecular probes for in vivo imaging of histone deacetylase (HDAC) in brain.Am J Nucl Med Mol Imaging. 2013;4(1):29-38.
  • Seo YJ, Muench L, Reid A, Chen J, Kang Y, Hooker JM, Volkow ND, Fowler JS, Kim SW.Radionuclide labeling and evaluation of candidate radioligands for PET imaging of histone deacetylase in the brain.Bioorg Med Chem Lett. 2013 Dec 15;23(24):6700-5.
  • Kim SW, Hooker JM, Otto N, Win K, Muench L, Shea C, Carter P, King P, Reid AE, Volkow ND, Fowler JS.Whole-body pharmacokinetics of HDAC inhibitor drugs, butyric acid, valproic acid and 4-phenylbutyric acid measured with carbon-11 labeled analogs by PET.Nucl Med Biol. 2013 Oct;40(7):912-8.
  • Schroeder FA, Lewis MC, Fass DM, Wagner FF, Zhang YL, Hennig KM, Gale J, Zhao WN, Reis S, Barker DD, Berry-Scott E, Kim SW, Clore EL, Hooker JM, Holson EB, Haggarty SJ, Petryshen TL.A selective HDAC 1/2 inhibitor modulates chromatin and gene expression in brain and alters mouse behavior in two mood-related tests.PLoS ONE. 2013;8(8):e71323.
  • Schroeder FA, Chonde DB, Riley MM, Moseley CK, Granda ML, Wilson CM, Wagner FF, Zhang YL, Gale J, Holson EB, Haggarty SJ, Hooker JM.FDG-PET imaging reveals local brain glucose utilization is altered by class I histone deacetylase inhibitors.Neurosci Lett. 2013 Aug 29;550:119-24.
  • Diyabalanage HV, Granda ML, Hooker JM.Combination therapy: Histone deacetylase inhibitors and platinum-based chemotherapeutics for cancer.Cancer Lett. 2012 Sep 29.
  • Hooker JM, Kim SW, Reibel AT, Alexoff D, Xu Y, Shea C.Evaluation of [(11)C]metergoline as a PET radiotracer for 5HTR in nonhuman primates.Bioorg Med Chem. 2010 Nov 15;18(22):7739-45.
  • Hooker JM, Kim SW, Alexoff D, Xu Y, Shea C, Reid A, Volkow N, Fowler JS.Histone deacetylase inhibitor, MS-275, exhibits poor brain penetration: PK studies of [C]MS-275 using Positron Emission Tomography.Acs Chemical Neuroscience. 2010;1(1):65-73.
  • Schönberger M, Leggett C, Kim SW, Hooker JM.Synthesis of [11C]SSR149415 and preliminary imaging studies using positron emission tomography.Bioorg Med Chem Lett. 2010 May 15;20(10):3103-6.
  • Biegon A, Kim SW, Logan J, Hooker JM, Muench L, Fowler JS.Nicotine blocks brain estrogen synthase (aromatase): in vivo positron emission tomography studies in female baboons.Biol Psychiatry. 2010 Apr 15;67(8):774-7.
  • Liu L, Xu Y, Shea C, Fowler JS, Hooker JM, Tonge PJ.Radiosynthesis and bioimaging of the tuberculosis chemotherapeutics isoniazid, rifampicin and pyrazinamide in baboons.J Med Chem. 2010 Apr 8;53(7):2882-91.
  • Hooker JM.Modular strategies for PET imaging agents.Curr Opin Chem Biol. 2010 Feb;14(1):105-11. Review.
  • Hooker JM, Munro TA, Béguin C, Alexoff D, Shea C, Xu Y, Cohen BM.Salvinorin A and derivatives: protection from metabolism does not prolong short-term, whole-brain residence.Neuropharmacology. 2009 Sep;57(4):386-91.
  • Hooker JM, Patel V, Kothari S, Schiffer WK.Metabolic changes in the rodent brain after acute administration of salvinorin A.Mol Imaging Biol.;11(3):137-43.
  • Hooker JM, Reibel AT, Hill SM, Schueller MJ, Fowler JS.One-pot, direct incorporation of [11C]CO2 into carbamates.Angew Chem Int Ed Engl. 2009;48(19):3482-5.
  • Volkow ND, Fowler JS, Logan J, Alexoff D, Zhu W, Telang F, Wang GJ, Jayne M, Hooker JM, Wong C, Hubbard B, Carter P, Warner D, King P, Shea C, Xu Y, Muench L, Apelskog-Torres K.Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications.JAMA. 2009 Mar 18;301(11):1148-54.
  • Hooker JM, Schönberger M, Schieferstein H, Fowler JS.A simple, rapid method for the preparation of [11C]formaldehyde.Angew Chem Int Ed Engl. 2008;47(32):5989-92.
  • Hooker JM, O'Neil JP, Romanini DW, Taylor SE, Francis MB.Genome-free viral capsids as carriers for positron emission tomography radiolabels.Mol Imaging Biol.;10(4):182-91.
  • Hooker JM, Xu Y, Schiffer W, Shea C, Carter P, Fowler JS.Pharmacokinetics of the potent hallucinogen, salvinorin A in primates parallels the rapid onset and short duration of effects in humans.Neuroimage. 2008 Jul 1;41(3):1044-50.
  • Datta A, Hooker JM, Botta M, Francis MB, Aime S, Raymond KN.High relaxivity gadolinium hydroxypyridonate-viral capsid conjugates: nanosized MRI contrast agents.J Am Chem Soc. 2008 Feb 27;130(8):2546-52.
  • Hooker JM, Datta A, Botta M, Raymond KN, Francis MB.Magnetic resonance contrast agents from viral capsid shells: a comparison of exterior and interior cargo strategies.Nano Lett. 2007 Aug;7(8):2207-10.
  • Kovacs EW, Hooker JM, Romanini DW, Holder PG, Berry KE, Francis MB.Dual-surface-modified bacteriophage MS2 as an ideal scaffold for a viral capsid-based drug delivery system.Bioconjug Chem.;18(4):1140-7.
  • Johnson HR, Hooker JM, Francis MB, Clark DS.Solubilization and stabilization of bacteriophage MS2 in organic solvents.Biotechnol Bioeng. 2007 Jun 1;97(2):224-34.
  • Hooker JM, Esser-Kahn AP, Francis MB.Modification of aniline containing proteins using an oxidative coupling strategy.J Am Chem Soc. 2006 Dec 13;128(49):15558-9.